Physician profile
Christopher Comstock
NPI 1174554539
$31,931.21
in general payments reported to CMS, 2019-2025
9 companies · $180 in 2025
The $180 reported for 2025 was more than what a typical Diagnostic Radiology provider received nationally (typical 2025 total: $112).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,898 · 2020: $1,500 · 2021: $1,000 · 2022: $13K · 2023: $6,437 · 2024: $5,676 · 2025: $180.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $11K · Food and Beverage: $620 · Travel and Lodging: $472.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $11,200.00 |
| Food and Beverage | $619.62 |
| Travel and Lodging | $472.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $12,491.46 | 2022 | |
| Bracco Diagnostics INC. | $6,281.83 | 2019-2021 | |
| Hologic INC | $6,138.44 | 2023 | 3dimensions |
| Bayer Healthcare LLC | $5,878.71 | 2023-2025 | |
| Guerbet LLC | $750.00 | 2022 | |
| Ge Healthcare | $241.61 | 2019-2023 | |
| Stryker Corporation | $82.28 | 2025 | Pangea |
| Olea Medical | $44.09 | 2024 | |
| Hologic Sales and Service, LLC | $22.79 | 2023 | 3dimensions |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Comstock listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.